DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CFO Blake Jeffrey Grayson sold 14,036 shares of the stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $55.47, for a total value of $778,576.92. Following the transaction, the chief financial officer now owns 87,611 shares of the company’s stock, valued at approximately $4,859,782.17. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Blake Jeffrey Grayson also recently made the following trade(s):
- On Thursday, June 20th, Blake Jeffrey Grayson sold 49,123 shares of DocuSign stock. The shares were sold at an average price of $51.15, for a total value of $2,512,641.45.
DocuSign Stock Performance
DocuSign stock opened at $56.64 on Thursday. DocuSign, Inc. has a fifty-two week low of $38.11 and a fifty-two week high of $64.76. The stock has a market cap of $11.60 billion, a P/E ratio of 108.92, a price-to-earnings-growth ratio of 5.99 and a beta of 0.93. The firm’s fifty day moving average price is $55.76 and its 200-day moving average price is $56.13.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several recent research reports. Royal Bank of Canada lifted their target price on shares of DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research note on Friday, September 6th. Wells Fargo & Company boosted their target price on shares of DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday, September 6th. Robert W. Baird raised their price target on DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Morgan Stanley reduced their price target on DocuSign from $65.00 to $62.00 and set an “equal weight” rating for the company in a research report on Friday, June 7th. Finally, Piper Sandler dropped their price objective on DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a report on Friday, June 7th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, DocuSign has an average rating of “Hold” and a consensus price target of $61.45.
Read Our Latest Report on DOCU
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. American Trust purchased a new position in DocuSign in the 2nd quarter worth $281,000. Sanctuary Advisors LLC purchased a new position in shares of DocuSign in the second quarter worth about $942,000. Clearbridge Investments LLC lifted its stake in shares of DocuSign by 4.1% in the 2nd quarter. Clearbridge Investments LLC now owns 2,920,842 shares of the company’s stock valued at $156,265,000 after acquiring an additional 115,616 shares during the last quarter. Truist Financial Corp boosted its holdings in DocuSign by 18.1% during the 2nd quarter. Truist Financial Corp now owns 9,138 shares of the company’s stock valued at $489,000 after acquiring an additional 1,399 shares during the period. Finally, Quarry LP bought a new position in DocuSign during the 2nd quarter worth approximately $53,000. 77.64% of the stock is currently owned by institutional investors.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- What is a SEC Filing?
- 3 Stocks with Upgraded Ratings: Analysts Predict More Upside
- Find and Profitably Trade Stocks at 52-Week Lows
- Why General Mills Is the Perfect Hedge for S&P 500 Volatility
- How to Invest in the FAANG Stocks
- Viking Therapeutics Is Having a Year to Remember: Time to Buy?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.